 | Up a level |
2018
Dorneburg, C., Fischer, M., Barth, T. F. E., Mueller-Klieser, W., Hero, B., Gecht, J., Carter, D. R., de Preter, K., Speleman, F., Marshall, G. M., Christner, L., Debatin, K. M. and Beltinger, C. (2018). LDHA Predicts Poor Survival in Neuroblastoma and its Depletion Causes Aerobic Glycolysis-Independent Inhibition of Neuroblastoma Cells. Pediatr. Blood Cancer, 65. S. S238 - 1. HOBOKEN: WILEY. ISSN 1545-5017
2014
Haber, M., Murray, J., Gamble, L., Carnegie-Clark, A., Webber, H., Ruhle, M., Carter, D., Oberthur, A., Fischer, M., Ziegler, D., Marshall, G. M., Gurova, K., Burkhart, C., Purmal, A., Gudkov, A. V. and Norris, M. D. (2014). CBL0137, a novel NFkB suppressor and p53 activator, is highly effective in pre-clinical models of neuroblastoma. Eur. J. Cancer, 50. S. 135 - 136. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852